TELESCOPE- TELEhealth Shared Decision-making COaching
ConditionLung Neoplasms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRutgers, The State University of New Jersey
About this trial
Hypothesis 1a: The investigators anticipate that navigator decision coaching, compared to enhanced usual care (EUC) will result in higher quality SDM for lung cancer screening (LCS )(primary outcome), greater knowledge of lung cancer screening benefits and harms, and lower decisional conflict.
Hypothesis 1b: Compared to enhanced usual care (EUC), we expect that TELESCOPE will result in more screening discussions, increased initial for lung cancer screening (LCS) with low-dose CT scan (LDCT) uptake among interested participants, increased adherence to repeat LCS and diagnostic testing, and increased smoking cessation referrals for current smokers.
Hypothesis 2: The investigators expect that a "booster" coaching session will increase adherence to repeat lung cancer screening (LCS).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Be 50 to 77 years of age
Be a current or former smoker having quit within the past 15 years
Have at least a 20 pack-year smoking history
Be scheduled for a non-acute care visit at one of the study sites. Interviews (N=50)
Disqualifiers
Do not speak English
Have a history lung cancer
Were screened for lung cancer within the past 12 months
Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider
Trial design
Design model
Parallel
Treatments tested in this trial
TELESCOPE, Remote Decision Coaching with Navigation Intervention
BehavioralThe TELESCOPE intervention involves three complementary components: 1) decision aid and coaching for LCS, 2) referral of current smokers to evidence-based smoking cessation services, and 3) for participants interested in screening, navigation to complete LCS and diagnostic testing and oncology care as needed
Treatment groups
594 Participants
are divided into 2 treatment groupsGroup A: TELESCOPE interventionExperimental treatment 1 intervention
Group B: Enhanced usual care (EUC)No intervention 0 interventions
Trial outcomes
Primary outcomes
1
To assess shared decision making
Semi-structured interviews (qualitative data)
Time frame
The change in baseline, three months and five yearsSecondary outcomes
1
Tobacco treatment referral
Semi-structured interviews (qualitative data)
Time frame
The change in baseline, three months and five years2
Uptake of Low-Dose CT Screening for Lung Cancer
Proportion of participants who complete low-dose CT (LDCT) lung cancer screening within 6 months post-intervention.
Time frame
Within 6 months post-interventionOther outcomes
1
Receipt of tobacco treatment
Semi-structured interviews (qualitative data).
Time frame
The change in baseline, three months and five years2
Completion of diagnostic testing
Semi-structured interviews (qualitative data).
Time frame
The change in baseline, three months and five yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Rutgers, The State University of New Jersey
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov